We investigated whether variation in genes encoding CYP2E1 or acetaldehyde-metabolising enzymes (ALDH1A1, ALDH2) might alter the risk of AD in an adolescent Cape population with mixed ancestry by performing systematic haplotype association analyses to maximize the chances of capturing functional variation. The gene discussed is CYP2E1; the disease is Alzheimer disease.